Submitted by Anonymous (not verified) on 19 September 2023 - 13:34
Opinion/decision on a Paediatric investigation plan (PIP): Besponsa,Inotuzumab ozogamicin, decision type: , therapeutic area: , PIP number: P/0398/2022
Source:
Opinion/decision on a Paediatric investigation plan (PIP): Besponsa,Inotuzumab ozogamicin, decision type: , therapeutic area: , PIP number: P/0398/2022